(Reuters) -Siemens Healthineers on Wednesday reported fourth-quarter revenue slightly below analysts’ consensus as higher U.S. import tariffs weigh.
The German medical technology company’s group revenue was 6.32 billion euros ($7.37 billion) in the quarter, compared to the 6.45 billion euros expected by analysts polled by Vara Research.
Its full-year comparable revenue growth of 5.9% meanwhile came in at the top end of its annual guidance of 5.5% to 6%, but missed analysts’ expectations of 6.3%.
Siemens Healthineers expects comparable revenue growth to be between 5% to 6% next year, it said in the statement.
($1 = 0.8575 euros)
(Reporting by Marleen Kaesebier in Gdansk and Alexander Huebner in Munich; editing by Milla Nissi-Prussak)
Brought to you by www.srnnews.com
